Ticker
GRCECompany Name
GRACE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -12.78M | 0% | $ 0 |
3/31/2025 | $ -12.76M | 0% | $ 0 |
12/31/2024 | $ -16.92M | 0% | $ 0 |
9/30/2024 | $ -15.07M | 0% | $ 0 |
6/30/2024 | $ -14.51M | 0% | $ 0 |
3/31/2024 | $ -15.59M | 0% | $ 0 |
12/31/2023 | $ -48.89M | 0% | $ 0 |
9/30/2023 | $ -50.13M | 0% | $ 0 |
6/30/2023 | $ -51.55M | 0% | $ 0 |
3/31/2023 | $ -51.85M | 0% | $ 0 |
EBITDA / Revenues
(=) EBITDA %
EBITDA % for GRACE THERAPEUTICS INC is calculated as follows: EBITDA [ $ -17.79M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |